NE-CHMIMO

NE-CHMIMO
NE-CHMIMO.svg
Legal status
Legal status
Identifiers
CAS Number
Chemical and physical data
Formula C26H25NO
Molar mass 367.492 g·mol−1
3D model (JSmol)

NE-CHMIMO (CHM-018) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2] NE-CHMIMO is the 1-cyclohexylmethyl (instead of 1-pentyl) analogue of the first-generation synthetic cannabinoid JWH-018. The corresponding cyclohexylmethyl derivative of JWH-081 had also been reported several months earlier.[3]

See also[edit]

References[edit]

  1. ^ Verena Angerer; Philippe Bisel; Bjoern Moosmann; Folker Westphal; Volker Auwärter (June 2016). “Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative “NE-CHMIMO” using flash chromatography, GC-MS, IR and NMR spectroscopy”. Forensic Science International. doi:10.1016/j.forsciint.2016.05.031. PMID 27297324.
  2. ^ “NE-CHMIMO”. New Synthetic Drugs Database.
  3. ^ Karen Blakey; Sue Boyd; Sarah Atkinson; Jenna Wolf; Pim M. Slottje; Katrina Goodchild; Jenny McGowan (March 2016). “Identification of the novel synthetic cannabimimetic 8-quinolinyl 4-methyl-3-(1-piperidinylsulfonyl)benzoate (QMPSB) and other designer drugs in herbal incense”. Forensic Science International. 260: 40–53. doi:10.1016/j.forsciint.2015.12.001. PMID 26795397.